Daily Update: ICU Study Notes —Good Sam and More

ICU Study Notes--Cardiac Constants and Heart Function

1. The Heart’s Main Job

The heart’s job is to:

• Pump blood through two circulations:

  • Pulmonary circulation → sends blood to lungs for oxygen.

  • Systemic circulation → sends oxygen-rich blood to tissues.

Blood flow is one-way, controlled by valves:

• Atria → Ventricles → Arteries → Body/Lungs.

2. Electrical and Mechanical Activity

Term	Meaning	Function
Depolarization	Electrical stimulation	Causes contraction
Repolarization	Electrical relaxation	Causes relaxation

The electrical activity controls mechanical function.
Healthy circulation depends on both working together.

3. Left vs. Right Heart

Side	Function	Blood Type	Destination
Right Heart	Receives deoxygenated blood	CO₂-rich	Pumps to lungs (pulmonary artery)
Left Heart	Receives oxygenated blood	O₂-rich	Pumps to body (via aorta)

Left heart = oxygen delivery.
Right heart = CO₂ removal.

4. Oxygen and Carbon Dioxide Exchange

• Oxygen delivery depends on:

  • Heart rate

  • Cardiac contractility

  • Blood pressure

  • Hemoglobin & oxygen saturation (SpO₂ or PaO₂)

• CO₂ removal depends on:

  • Right heart function: RHF

  • Lung gas exchange (alveoli & capillaries)

5. Heart Rate (HR): The First Vital to Assess

Heart rate tells us how the body is compensating for oxygen needs.

When HR increases (tachycardia):

• Often a compensatory response to:

  • Low blood pressure (hypotension)

  • Low oxygen (hypoxia)

  • Fever or sepsis

  • Pain or anxiety

  • Exercise or metabolic stress

Persistent tachycardia = early warning sign something is wrong.

1. Why Does Sepsis Cause Low Blood Pressure (Hypotension)?

Mechanism:

Sepsis is an overwhelming systemic inflammatory response to infection. When bacteria or their toxins enter the bloodstream, the immune system releases massive amounts of inflammatory mediators (cytokines, nitric oxide, prostaglandins, etc.).

These mediators cause:

1. Vasodilation → blood vessels lose their tone and become “floppy.”

   • Result: ↓ Systemic Vascular Resistance (SVR) → blood pressure drops.

2. Increased capillary permeability → fluid leaks out of vessels into tissues.

   • Result: ↓ Intravascular volume (preload) → even lower BP.

3. Myocardial depression → inflammatory chemicals reduce heart’s ability to contract.

   • Result: ↓ Cardiac Output (CO) → further hypotension.

4. Poor tissue oxygenation → organs begin to fail if MAP < 65 mmHg.

In short:

Sepsis causes vasodilation + fluid leak + weak pump = distributive shock → low BP.

2. Why Are Beta Blockers Given to Patients With CHF (Chronic Heart Failure)?

Mechanism:

In CHF, the heart’s pumping ability (contractility) is chronically weak. The body compensates by activating the sympathetic nervous system (↑ adrenaline/norepinephrine), which increases HR and contractility in the short term, but this becomes harmful long-term.

Chronic sympathetic activation causes:

• Heart muscle remodeling (fibrosis, dilation)

• Increased oxygen demand

• Arrhythmias

• Faster progression of heart failure

Role of Beta Blockers:

Beta blockers (like metoprolol, carvedilol, bisoprolol) block the effects of adrenaline on the heart.

They:

1. Reduce heart rate → allows more time for ventricular filling (↑ stroke volume).

2. Decrease myocardial oxygen demand.

3. Prevent further cardiac remodeling.

4. Improve survival and reduce hospitalizations.

In short:

Beta blockers “slow the heart to save the heart.”
They protect it from overwork and allow recovery over time.

3. Why Are Labs Drawn Before Giving Antibiotics in Septic Patients?

Mechanism:

When sepsis is suspected, it’s critical to identify the causative organism so targeted antibiotics can be chosen.

If you give antibiotics before drawing cultures:

• The antibiotics can kill or suppress bacterial growth in the blood.

• This can lead to false-negative cultures, making it difficult to identify the source of infection.

Clinical Order:

1. Obtain cultures first: usually:

   • 2 sets of blood cultures from different sites

   • Urine, sputum, wound cultures if applicable

2. Then administer broad-spectrum antibiotics immediately after.

Timing is key:
Cultures first, but do not delay antibiotics more than 1 hour — every hour of delay increases mortality.

In short:

Draw labs before antibiotics so you know what organism caused the infection, but don’t wait too long to treat.

Summary Table

Condition	Core Problem	Physiologic Mechanism	Clinical Goal
Sepsis → Low BP	Vasodilation + leak + weak pump	↓ SVR, ↓ preload, ↓ CO	Maintain MAP ≥ 65 (fluids + pressors)
CHF → Beta Blockers	Chronic sympathetic overload	↓ HR, ↓ O₂ demand, prevent remodeling	Slow heart, improve EF, prolong survival
Sepsis → Labs Before Antibiotics	Need organism ID	Prevent false-negative cultures	Draw labs first, give antibiotics immediately after

6. Nervous System Control

The autonomic nervous system regulates HR:

System	Neurotransmitter	Effect on Heart
Sympathetic (fight/flight)	Epinephrine & norepinephrine	↑ HR, ↑ contractility
Parasympathetic (rest/digest)	Acetylcholine	↓ HR

Key nerve centers:

• Accelerator nerve → increases HR (via epinephrine).

• Vagus nerve (CN.X) → slows HR (via acetylcholine).

Key Biomarkers in Sepsis and Cardiac Events

I. Lactic Acid in Sepsis

What It Is

• Lactate (lactic acid) is a byproduct of anaerobic metabolism — the body’s way of producing energy when oxygen is insufficient.

• Normally, tissues use oxygen (aerobic metabolism) to make ATP.

• In sepsis, oxygen delivery to tissues is impaired → cells switch to anaerobic metabolism, producing lactic acid.

Why It Rises in Sepsis

1. Poor tissue perfusion:

   • Sepsis causes vasodilation, capillary leak, and hypotension → low MAP → reduced tissue oxygenation.

2. Mitochondrial dysfunction:

   • Even when oxygen is present, sepsis disrupts cellular use of oxygen.

3. Increased metabolic demand:

   • Inflammation and fever increase cellular oxygen consumption.

Why It’s a Big Marker

• Elevated lactate = evidence of tissue hypoperfusion even if BP is normal.

• Strongly correlates with severity of sepsis and mortality risk.

Normal & Critical Values

Lactate Level	Interpretation	Clinical Meaning
< 2 mmol/L	Normal	Adequate perfusion
2–4 mmol/L	Elevated	Early tissue hypoxia; "red flag"
> 4 mmol/L	Critically high	Septic shock or profound hypoperfusion

Clinical Actions

• Repeat lactate every 2–4 hours until it trends down.

• If persistently high → reassess fluids, perfusion, oxygenation, or source control.

In short:

Elevated lactate = tissues are “starving for oxygen” — even before BP drops.

II. Troponin in Cardiac Events

What It Is

• Troponin I/T are cardiac-specific proteins released when heart muscle cells are injured.

• Used to diagnose myocardial infarction (MI) and other cardiac injuries.

In Sepsis

• Troponin can also rise without an actual heart attack due to:

  1. Septic myocardial depression (toxic inflammatory effect on the heart)

  2. Hypotension and hypoxia (demand ischemia)

  3. Microvascular injury

Key point:

In sepsis, an elevated troponin does not always mean an MI, it may reflect cardiac stress or sepsis-related injury.

Normal & Elevated Ranges

Troponin	Normal	Elevated
Troponin I	< 0.04 ng/mL	≥ 0.04 ng/mL (acute injury likely)
Troponin T	< 0.01 ng/mL	≥ 0.01 ng/mL (cardiac injury)

III. BNP (B-type Natriuretic Peptide)

What It Is

• BNP is a hormone released from ventricles in response to stretch and volume overload.

• It helps promote diuresis, vasodilation, and sodium excretion.

Clinical Use

• Used to evaluate heart failure or volume status in dyspnea or shock.

BNP Level	Interpretation
< 100 pg/mL	Normal
100–400 pg/mL	Possible heart strain
> 400 pg/mL	Likely heart failure

In Sepsis

• BNP can also rise due to septic cardiomyopathy or renal dysfunction → must interpret carefully alongside clinical findings.

Key point:

Elevated BNP in sepsis often reflects stress-induced myocardial dysfunction or fluid overload, not necessarily chronic HF.

IV. Other Key Sepsis-Related Labs

Marker	Role / Significance
Procalcitonin (PCT)	Rises in bacterial infection → used to guide antibiotic therapy and monitor treatment response.
CRP (C-reactive protein)	Non-specific inflammatory marker — helps track infection trends.
WBC count	Elevated or low in infection; extremes indicate severe response.
Creatinine, BUN	Reflect renal perfusion and function (may rise in sepsis).
Liver enzymes (AST, ALT, Bilirubin)	May increase due to hypoperfusion (shock liver).
Coagulation (INR, D-dimer, Platelets)	May be deranged in sepsis-induced DIC.

V. The Sepsis Bundle (Surviving Sepsis Campaign Guidelines)

Most acute care hospitals follow a 1-hour or 3-hour bundle to ensure rapid, standardized response.

1-Hour Sepsis Bundle (latest version)

Initiate all within 1 hour of recognition:

1. Measure lactate level

   • Re-measure if > 2 mmol/L.

2. Obtain blood cultures

   • Before starting antibiotics.

3. Administer broad-spectrum antibiotics.

4. Begin rapid fluid resuscitation

   • 30 mL/kg crystalloid for hypotension or lactate ≥ 4 mmol/L.

5. Apply vasopressors if hypotension persists after fluids

   • To maintain MAP ≥ 65 mmHg.

6. Reassess perfusion (repeat lactate, urine output, mental status, capillary refill).

VI. How It All Ties Together

Marker	What It Tells You	Why It Matters
Lactate	Tissue oxygenation / perfusion	High = anaerobic metabolism, worse outcomes
Troponin	Myocardial injury	Distinguish MI vs septic myocardial strain
BNP	Ventricular stretch / volume overload	Guides fluid management in sepsis with cardiac dysfunction
Procalcitonin	Bacterial infection marker	Helps start/stop antibiotics
Creatinine	Kidney perfusion	Evaluates shock impact on renal system
Coags & Platelets	Clotting function	Detects DIC, common in severe sepsis

A Brief Summary:

• Lactate: Sepsis severity marker (O₂ debt).

• Troponin: Myocardial stress/injury.

• BNP: Cardiac stretch and fluid overload.

• Procalcitonin: Confirms bacterial infection.

• Bundle: Time = tissue → act fast within 1 hour.

7. Receptors Affecting Heart Rate

The medulla oblongata in the brainstem controls HR by processing signals from:

Receptor Type	What It Detects	Result
Baroreceptors	Pressure/stretch	Adjust HR based on volume
Chemoreceptors	CO₂ ↑ or O₂ ↓	Increase HR and breathing
Thermoreceptors	Temperature	Increase HR when hot
Muscle stretch receptors	Activity/exertion	Adjust HR accordingly

8. Critical Warning Signs

Condition	What It Means
Tachycardia with hypotension	Body is compensating — check oxygen and perfusion
Bradycardia with hypotension	Always abnormal and dangerous, unless induced medically
Persistent tachycardia	Early sign of oxygen delivery problem

9. Chemical and Hormonal Regulation

Factor	Effect on Heart
Adrenal glands	Release epinephrine → ↑ HR
Acidosis (low pH)	↑ HR (sympathetic stimulation)
Alkalosis (high pH)	↓ HR (parasympathetic)
Thyroid hormone	Hyperthyroidism → ↑ HR / Hypothyroidism → ↓ HR
Vasopressin	Helps maintain vascular tone

10. Electrolytes and Heart Function

Electrolyte	Function	Abnormality
Potassium (K⁺)	Needed for electrical activity	Too high or low → arrhythmias
Calcium (Ca²⁺)	Needed for muscle contraction	Low calcium → weak contractions, vasodilation

Note:

• Blood transfusions use citrate, which binds calcium → may cause low calcium (hypocalcemia) → ↓ contractility.

• Calcium must be replaced during massive transfusion.

11. Relationship Between HR, Filling, and Stroke Volume

When HR is too high, there’s:

• Less time for the heart to fill between beats.

• Less blood ejected per beat (low stroke volume).

Example:

Normal HR (60 bpm): Fill → Eject → Fill → Eject
HR 120 bpm: Eject! Eject! Eject! — No time to fill → cardiac output drops.

That’s why persistent tachycardia is dangerous, it reduces oxygen delivery even though HR is high.

12. Clinical Takeaways

Always identify the cause of tachycardia before treating.
Do not immediately give beta-blockers for tachycardia in a critically ill patient.
Bradycardia + hypotension = red flag.
Calcium replacement is essential after multiple blood transfusions.
Persistent tachycardia often signals early cellular hypoxia or metabolic acidosis.

Summary:

• The heart’s electrical system drives mechanical pumping.

• The autonomic nervous system finely tunes HR and contractility.

• Tachycardia is the body’s first line of defense against low oxygen or volume.

• Bradycardia + hypotension means imminent danger.

• Oxygen delivery = HR × Stroke Volume × Hemoglobin × Oxygen saturation.

• Stable rhythm and balanced chemistry = stable patient.

Understanding SVO₂, SCVO₂, and Cardiac Output

 1. The Big Picture

Your heart and blood vessels are like a delivery system.

• The heart is the pump.

• The blood is the delivery truck.

• The oxygen is the package being delivered to every cell.

So, if the body’s oxygen “delivery service” is working well, the tissues get enough oxygen to do their jobs.
If it’s not — tissues become starved of oxygen and start to fail.

2. Key Measurements

Term	Full Name	What It Tells Us	Normal Range
SVO₂	Mixed Venous Oxygen Saturation	% of oxygen left in the blood after it passes through the body	60–80%
SCVO₂	Central Venous Oxygen Saturation	Same idea, but measured from blood in the superior vena cava (upper body)	65–75%
Cardiac Output (CO)	The total amount of blood the heart pumps in 1 minute	CO = HR × Stroke Volume	4–8 L/min
Cardiac Index (CI)	CO adjusted for body size (surface area)	CI = CO / Body Surface Area	2.5–4.2 L/min/m²
Stroke Volume (SV)	Amount of blood ejected by one ventricle in one beat	—	60–100 mL/beat

3. Understanding SVO₂ and SCVO₂

Think of SVO₂ and SCVO₂ as oxygen “leftovers.”
When blood leaves the heart, it’s full of oxygen (like a full delivery truck).
When it comes back, the body has used some — what’s left is your venous oxygen.

• If SVO₂ is high → the body is not using much oxygen (could be from poor tissue extraction, like in sepsis).

• If SVO₂ is low → the body is using a lot of oxygen, maybe because delivery (cardiac output) is too low.

Simple Rule:

Oxygen Delivery = Cardiac Output × Oxygen in Blood
Oxygen Consumption = How much oxygen cells are using

If delivery is too low or consumption is too high → SVO₂ drops.

 4. Difference Between SVO₂ and SCVO₂

Feature	SVO₂	SCVO₂
Blood Sample Site	Pulmonary artery (via PA catheter)	Superior vena cava (via central line)
Represents	All blood returning from the body	Mostly upper body
Accuracy	More complete picture	Easier, less invasive
Normal Difference	SCVO₂ is usually 3–5% higher than SVO₂

Because SCVO₂ doesn’t include as much lower-body blood (which uses more oxygen), it’s slightly higher.

5. Why Compare SVO₂ and SCVO₂?

When there’s a big gap between them — it may signal something important:

• SCVO₂ normal but SVO₂ low: lower body (like gut or legs) isn’t getting enough oxygen.

• Both low: cardiac output or oxygen delivery problem.

• Both high: tissues aren’t using oxygen properly (as in sepsis or cyanide poisoning).

6. Example (from your lecture)

Patient	SCVO₂	SVO₂	CO	CI	HR	BP	SV	Interpretation
A	?	?	?	?	?	?	?	Needs more info
B	35%	22%	7.8 L/min	4.2	135	120/30	57	Low venous oxygen → tissues are starving for O₂ even though CO is high; likely septic shock or distributive shock

Even though Patient B’s cardiac output is high, the oxygen levels returning are very low.
→ Blood is being pumped fast, but cells aren’t getting enough oxygen.

7. The Missing Piece

When interpreting these numbers, one more thing would make the picture clearer:
Hemoglobin and Lactate.

Why?

• Hemoglobin carries oxygen — low Hb means less oxygen delivery.

• Lactate rises when tissues can’t get enough oxygen — it’s like a distress signal.

So, with SVO₂, SCVO₂, CO, and lactate, you can understand how well the body is delivering and using oxygen.

Summary

Concept	In Simple Terms
Cardiac Output	How fast the trucks are moving
Hemoglobin (Hb)	How many packages each truck carries
SVO₂ / SCVO₂	How much oxygen is left after delivery
Lactate	Alarm signal that says “we’re not getting enough oxygen!”

Signs of Decompensation

Introduction

• The goal in critical care is early identification and intervention for patients at risk of deterioration.

• Focus on recognizing what problem might kill the patient first and address that rapidly.

• Many critical patients (e.g., with sepsis, COVID-19, multi-organ failure) are unstable-small changes in fluids, vasopressors, or positioning can worsen their condition.

Main Goal: Maintain Adequate Perfusion

• All interventions aim to ensure adequate perfusion and oxygen delivery.

• Learn to detect:

  • Poor perfusion → inadequate tissue oxygenation.

  • Excess perfusion → potential fluid overload, pulmonary edema, etc.

• Therapy is titrated to specific hemodynamic and organ function endpoints.

The Chain of Safety

1. Observation and Documentation – Recognize small clinical changes.

2. Alert and Communicate – Notify the team using clear, evidence-based statements.

3. Respond and Intervene – Perform rapid, science-based interventions.

4. Reassess – Evaluate if interventions improved patient status.

Example:
Instead of saying “The patient is agitated; I had to increase sedation,”
say:
“The patient’s RR and HR have increased. He’s asynchronous with the ventilator. I’m increasing sedation to improve ventilation and oxygenation.”

Recognizing Early Deterioration

• Decompensation rarely happens suddenly.

  • Most patients show signs 2–6 hours before arrest or intubation.

  • 84% of cardiac arrests are preceded by respiratory or mental deterioration.

  • 66% show warning signs 6 hours prior.

Rule: Always compare what the patient looked like before vs. now.
Subtle changes = early red flags.

Major Systems to Evaluate

A – Airway and B – Breathing

• Watch for:

  • Rapid respiratory rate (#1 sign of decompensation)

  • Use of accessory muscles

  • Changes in breathing pattern or depth

• Increased RR = Early warning of deterioration across all age groups.

• Pulse oximetry drops 2–3 minutes after the actual event, so RR changes first.

Respiratory Rate and Metabolic Acidosis

• Increased RR is usually compensatory for metabolic acidosis until proven otherwise.

• Two key acids in blood:

  • Hydrogen ion (H⁺) → metabolic acid.

  • CO₂ → respiratory acid.

• When acid builds up → RR and depth increase to blow off CO₂.

The “Rule of 20”

Use chemistry panel to detect metabolic acidosis:

1. Total CO₂ < 20 → metabolic acidosis likely.

2. Anion gap > 20 → metabolic acidosis likely.

3. ABG: Low HCO₃⁻ or base deficit = metabolic acidosis.

Don’t immediately sedate a tachypneic patient — find the cause first.

Oxygenation Monitoring

Test	Measures	Notes
PaO₂	Oxygen dissolved in plasma	Readily usable by tissues
SaO₂	O₂ bound to hemoglobin	Must dissociate to be used
SpO₂ (Pulse Ox)	Estimate of SaO₂	Delayed reflection (2–3 min)
VBG / SvO₂	Venous O₂ content	Reflects tissue extraction (covered later)

Circulation

Early Signs

• Tachycardia (2nd most common sign of illness)

• Cool, pale, or mottled extremities

• Decreased urine output

• Mental status changes

• Weak peripheral pulses

Tachycardia

• Persistent tachycardia is never normal → always compensatory.

• Common causes: hypovolemia, pain, fever, hypoxia, acidosis, early sepsis.

New Onset Atrial Fibrillation

• Often indicates acute decompensation or myocardial strain.

Blood Pressure:

• Requires both blood flow and vascular tone to measure.

• Two components:

  • Systolic →ventricular ejection.

  • Diastolic →vascular tone.

• Mean Arterial Pressure (MAP):

  • Normal range: 65–85 mmHg (adjust for patient history).

  • MAP < 65 → organ hypoperfusion risk.

Key Interventions:

• Improve blood flow: Fluids, inotropes.

• Improve vascular tone: Vasopressors.

Note:

• BP drops late in deterioration — focus on earlier signs like RR and HR.

Blood Pressure Monitoring Methods

1. Oscillometric (Dinamap) – Intermittent snapshot.

2. Arterial Line (A-line) – Continuous, invasive, best accuracy.

3. Noninvasive Continuous (e.g., ClearSight finger cuff) – Continuous trend without A-line.

Neurologic: Mental Status Changes

3 Major Sign of Decompensation

• Early subtle changes in mental function = early hypoperfusion.

• Mental status has two parts:

  • Arousal – ability to wake up or respond (brainstem level).

  • Awareness – ability to process, understand, and respond meaningfully.

Delirium and Fluctuating Awareness

• Seen commonly in ICU, especially with sedation or pain meds.

• Delirium is fluctuating, patient may be clear in the morning and confused later.

Assessment Tools

Tool	Purpose
Glasgow Coma Scale (GCS)	Basic consciousness and arousal
CAM-ICU	Detects delirium and mental status change
RASS (Richmond Agitation-Sedation Scale)	Measures arousal/agitation level

Example bedside checks:

• Orientation: “Where are you right now?”

• Cognition: “What does ‘a rolling stone gathers no moss’ mean?”

• Memory: Ask patient to recall and show a simple task after a delay.

Key Takeaways

1. Rapid respiratory rate = earliest and most reliable sign of deterioration.

2. Persistent tachycardia = never benign; always investigate.

3. Acute mental status change often signals poor cerebral perfusion or hypoxia.

4. Blood pressure drops late — act before it does.

5. Small, multi-system changes (mild ↑RR + mild ↑HR + slight confusion) = high-risk pattern.

6. Effective communication must describe the measurable change and the intended intervention.

Summary Table: Early Warning Signs of Decompensation

System	Early Sign	Likely Cause	Immediate Action
Airway/Breathing	↑ RR, use of accessory muscles	Metabolic acidosis, hypoxia	Assess ABG, check tubing, avoid oversedation
Circulation	↑ HR, cool extremities, ↓ urine	Hypoperfusion, sepsis	Assess fluid status, MAP, give fluids/inotropes
Neurologic	Confusion, lethargy	↓ Cerebral perfusion, hypoxia, drug effect	Reassess hemodynamics, evaluate O₂ and glucose
Overall	Subtle changes across systems	Early decompensation	Communicate early, intervene quickly

Final Thought:

“Be afraid of one big change; be alert to many small ones.”
Early recognition saves lives — small, timely interventions prevent full decompensation.

Cardiogenic Shock & Mechanical Circulatory Support (MCS)

1. Intro: 

• Focus: Revisiting shock, especially cardiogenic shock (CS) and mechanical circulatory support (MCS).

• Goal: Provide a heuristic toolkit for evaluating and applying MCS to patient physiology and hospital capabilities.

2. Redefining Shock

• Shock ≠ Hypotension only — can occur with normal BP (occult shock).

• A multi-system pathology from cellular → organ dysfunction.

• Key components:

  • Congestion → visceral organ dysfunction.

  • Malperfusion → altered capillary refill, mental status.

• Must always ask: Does this patient show circulatory compromise?

3. Types of Shock

• Distributive → ↓SVR (e.g. sepsis).

• Hypovolemic → ↓preload (bleeding, dehydration).

• Cardiogenic → ↓CO.

4. Cardiogenic Shock (CS) Overview

• Definition: Inadequate cardiac output → systemic hypoperfusion.

• Mortality: ~30–40% despite modern care.

• Pathophysiology: Can be LV, RV, or biventricular failure.

• Key bedside clues:

  • LV failure → ↑LVEDP / ↑wedge pressure.

  • RV failure → ↑CVP.

  • Combined failure → both pressures high.

5. Causes of Cardiogenic Shock

• AMI-related CS (most common)

• Acute valvular disease (MR, AI)

• LVOT obstruction (dynamic, e.g. septic shock hypercontractility)

• Obstructive syndromes (tamponade, PE, pneumothorax)

• Arrhythmia-induced CS

6. SCAI Classification of CS (SKY Pyramid)

Stage	Description	Mnemonic
A	At risk	“At risk”
B	Beginning hypoperfusion	“Beginning”
C	Classic hypotension	“Cold”
D	Deteriorating	“Dying”
E	Extremis	“End-stage”

• Higher stage → higher mortality.

• Dynamic staging (trajectory over time) is prognostically critical.

7. Treatment Strategy

Step 1: Identify and Reverse Cause

• AMI-CS: Early revascularization (culprit vessel only).

  • Complete revascularization ↑mortality due to longer procedure, ↑contrast load.

Step 2: Optimize Hemodynamics

• Fluids: Usually restrict (avoid overload).

• Inotropes: Support contractility (short-term bridge).

• Vasopressors: Maintain MAP, but use cautiously.

  • Avoid dopamine (↑mortality in CS – SOAP II trial).

  • Use norepinephrine as preferred pressor.

  • Dobutamine vs. Milrinone (CAPITAL DOME trial) → no significant difference in outcomes.

8. Mechanical Circulatory Support (MCS)

Use when pharmacologic therapy fails or as early adjunct.

Goals of MCS (“Hemodynamic Equation”):

1. Maintain perfusion (MAP, organ blood flow)

2. Decrease ventricular workload

3. Improve coronary perfusion

4. Decongest visceral organs

9. Common MCS Devices

A. Intra-Aortic Balloon Pump (IABP)

• Oldest device; percutaneous balloon in descending aorta.

• Inflates in diastole, deflates in systole.

• Mechanism:

  • ↑Coronary perfusion (↑diastolic pressure).

  • ↓Afterload (↓LV wall stress).

• Limitation: Minimal CO support (~0.5 L/min).

• IABP-SHOCK II trial: No mortality benefit in AMI-CS.

B. Veno-Arterial ECMO (VA-ECMO)

• Components: Venous drainage → pump/oxygenator → arterial reinfusion.

• Provides:

  • Full hemodynamic support (~5 L/min).

  • Respiratory support (O₂/CO₂ exchange).

• Drawback: Retrograde aortic flow ↑LV afterload → LV distension, ↑wall stress, ↓coronary perfusion.

• Complications: Limb ischemia, bleeding, thrombosis, infection, renal failure.

• Outcome: Trials show no clear mortality benefit due to LV overload.

C. Impella (Transaortic Microaxial Flow Pump)

• Inserted across the aortic valve via femoral/axillary artery.

• Drains LV → aorta (continuous suction).

• Effects:

  • ↓LVEDV, ↓LV work, ↑unloading (“ventricle rest”).

  • Flow up to 5.5 L/min depending on model.

• DANGER Trial (2024):

  • Improved 180-day mortality (NNT=8).

  • Harms: Bleeding, hemolysis, renal failure (NNH=6).

  • Effect strongest in non-arrest AMI-CS.

D. Combined ECMO + Impella (“ECPELLA”)

• Used for severe biventricular failure.

• ECMO → systemic flow & oxygenation.

• Impella → LV decompression.

• Potential benefits: ↓LV overload, improved survival (early use).

• Risks: Bleeding, vascular injury, ↑renal failure due to dual cannulation.

10. MCS Device Selection

Situation	Preferred Device
True emergency / arrest / PE	VA-ECMO (rapid bedside cannulation)
Predominant LV failure (recoverable)	Impella / LV assist device
Biventricular failure	VA-ECMO ± LV venting (Impella)
Need for oxygenation + circulation	VA-ECMO
Need for LV unloading only	Impella / IABP

11. Institutional Readiness

• Develop a team: Cardiology, ICU, perfusion, nursing, surgery.

• Establish protocols: Early recognition, escalation, transfer criteria.

• Volume = Quality: High-use centers have better outcomes.

12. Right Ventricular (RV) Shock & Pulmonary Embolism (PE)

• Common cause: Massive PE → RV overload, dilation, ↓output.

• Therapeutic goal: Unload RV, maintain systemic perfusion while treating clot.

MCS Options for RV Failure

Device	Mechanism	Comment
RV Impella (Impella RP)	Suction RA → PA	Doubles CO, ↓CVP
RVAD	External assist device	Complex setup
VA-ECMO	Biventricular + oxygenation	Best for PE with arrest or severe hypoxia

• RECOVER RIGHT Trial:

  • Proof-of-concept: ↑CO, ↓CVP in RV failure (post-LVAD or MI).

• Challenges in PE:

  • Dilated chambers, clot transit, risk of embolization.

  • Requires fluoroscopy + TEE guidance (not for crash cases).

  • ECMO often first-line in PE-related cardiac arrest.

13. ECMO in Massive PE

• NIS (2016–2018): ECMO reduced mortality by 39%.

• ELSO registry: ECMO associated with higher survival in PE-related arrest vs other causes.

• Complications: Same as in LV failure—bleeding, renal failure, infection.

14. Summary – Approach to Shock & MCS

1. Recognize shock early.

2. Classify (SCAI stages, LV vs RV vs both).

3. Treat cause (revascularization, thrombolysis).

4. Optimize hemodynamics: Fluids, inotropes, vasopressors.

5. Escalate to MCS if unresponsive—based on phenotype and device suitability.

6. Iterate assessments — dynamic staging is prognostic.

7. Establish systems of care — training, readiness, interhospital coordination.

Key Takeaways:

• Cardiogenic shock remains highly lethal; early recognition and mechanical support are lifesaving.

• Hemodynamic reasoning (LV load, afterload, perfusion) guides MCS selection.

• Impella unloads; ECMO supports but loads the LV.

• Combining devices may balance flow and unloading when used early.

• Team coordination, experience, and rapid escalation are crucial to survival.

Sedation in Mechanically Ventilated Patients

I. Overview & Objectives

• Purpose of Sedation:

  • Therapeutic: Facilitates mechanical ventilation, reduces oxygen consumption and metabolic demand.

  • Humanistic: Reduces psychological distress and discomfort.

  • Protective: Prevents self-extubation, removal of lines, and injury.

• Main Goal:

  • Use the least amount of sedation necessary for the shortest duration possible.

  • Maintain patients calm, comfortable, and interactive if feasible.

II. Harms of Deep Sedation

• Early deep sedation (within 48 hrs of intubation):

  • ↑ Mechanical ventilation duration

  • ↑ ICU length of stay

  • ↑ Mortality

• Long-term outcomes:

  • Continuous IV sedation → poor physical function at 6 months post-ICU.

  • Associated with delirium, immobility, and post-ICU cognitive dysfunction.

III. General Sedation Principles

• Sedation is not therapeutic; it’s a necessary evil to ensure synchrony with the ventilator.

• Exceptions:

  • Paralyzed, cooled, ECMO, or status epilepticus patients may require deep sedation.

• Target: Light sedation unless clinically contraindicated.

  • Example: RASS -2 to 0

IV. Sedative Agents

A. Propofol

• Mechanism: Potentiates GABA.

• Onset/Offset: Rapid on and off.

• Advantages:

  • Easy titration, rapid awakening.

  • Independent of renal/liver metabolism.

• Disadvantages:

  • Hypotension, bradycardia, hypertriglyceridemia.

  • Propofol Infusion Syndrome (PRIS):

    • Rare, life-threatening mitochondrial dysfunction → metabolic acidosis, rhabdo, cardiac failure.

    • Risk: >4 mg/kg/hr or prolonged use.

    • Treatment: Stop propofol, supportive care, possible RRT.

B. Benzodiazepines (Midazolam, Lorazepam)

• Mechanism: GABA agonists.

• Pros: Fewer hemodynamic effects.

• Cons: Active metabolites, long duration.

• Major Issues:

  • Associated with ↑ delirium, ↑ mortality, ↑ PTSD and depression post-ICU.

• Avoid unless necessary.

C. Dexmedetomidine

• Mechanism: Alpha-2 agonist (similar to clonidine, 8× affinity).

• Advantages:

  • Sedation without respiratory depression.

  • Decreases delirium, facilitates extubation.

• Disadvantages:

  • Bradycardia, hypotension, central fever.

  • Not strong enough for first-line use.

• Best Use: As adjunct during weaning/extubation of agitated/delirious patients.

D. Ketamine

• Mechanism: NMDA receptor antagonist.

• Properties: Dissociative, bronchodilator, preserves respiratory drive.

• Side Effects: Tachycardia, possible accumulation with prolonged use.

• Evidence:

  • ↓ Delirium but ↑ ICU length of stay.

  • No mortality benefit.

• Best Use: Adjunct in bronchospastic disease (COPD, asthma).

E. Opioids

• Purpose: Analgesia for pain-related agitation and air hunger.

• Preferred agent: Hydromorphone (Dilaudid) over fentanyl (less context-sensitive).

• Strategy: Bolus first → infusion only if repeated doses required.

• Risks: ↑ Delirium (dose-dependent), respiratory depression.

• Opioid Use Disorder (OUD):

  • Continue maintenance therapy (methadone, buprenorphine) with pharmacy guidance.

  • Uncontrolled pain can trigger relapse.

V. Special Populations

ECMO Patients

• Require higher doses (drug sequestration in circuit).

• May need deeper sedation due to:

  • Venous collapse risk

  • Flow variability

  • Blood pressure fluctuations → risk of intracranial hemorrhage.

• Some ECMO patients can tolerate no sedation (e.g., ambulating bridge-to-transplant cases).

Inhaled Anesthetics (e.g., Sevoflurane)

• Recent Cesar Trial (2024, France):

  • Compared Sevoflurane vs Propofol in severe ARDS.

  • Result: ↑ ventilation duration, ↑ 90-day mortality with inhaled anesthetic.

  • Conclusion: Not ready for clinical routine use.

VI. Guidelines (SCCM Updates)

• 2013: Prefer non-benzodiazepine strategies.

• 2018: Recommend light sedation (RASS -2 to 0).

  • Prefer Propofol or Dexmedetomidine as first-line.

VII. Sedation Maintenance & Weaning

• Reassess sedation goals daily.

  • Use standardized scales (e.g., RASS).

  • Titrate down whenever stable.

• Daily Sedation Awakening Trial (SAT):

  • Hold sedation → evaluate if patient can remain calm.

  • Restart at lower dose if necessary.

• Weaning:

  • If <1 week: taper as tolerated.

  • If >1 week: ↓ by ≤25% per day to avoid withdrawal.

  • Consider oral agents or transdermal patches for taper.

VIII. ABCDE Bundle

Component	Meaning	Purpose
A	Awakening (Daily SAT)	Reduce over-sedation
B	Breathing (SBT)	Assess readiness for extubation
C	Coordination	Combine SAT + SBT to expedite liberation
D	Delirium	Monitor (CAM-ICU), manage non-pharmacologically
E	Early Mobility	Prevent weakness, improve outcomes

• ABC Trial:

  • Protocolized daily SAT + SBT → ↓ vent days, ↓ ICU stay, ↓ 1-year mortality.

  • ↑ self-extubation but no increase in reintubation.

When not to perform SAT:

• Deep sedation required (paralysis, cooling, ECMO)

• Low tidal volume ventilation (ARDS)

• Hemodynamic instability (pressors, active shock)

IX. Delirium

• Common, often linked to:

  • Benzodiazepine & opioid exposure

  • Deep sedation

  • Immobility

• Outcomes:

  • 3× higher 6-month mortality

  • Long-term cognitive impairment

• Management:

  • Avoid deep sedation

  • Use light sedation, mobilize early, reorient patients frequently.

X.  Takeaways

1. Light sedation = better survival, shorter ventilation, less delirium.

2. Propofol and Dexmedetomidine preferred first-line.

3. Avoid benzodiazepines unless absolutely needed.

4. Opioids for analgesia, not for sedation.

5. Daily SAT/SBT should be routine.

6. Always titrate to the lowest effective dose and reassess daily.

Acute Respiratory Distress Syndrome (ARDS)

1. Definition

ARDS = Acute, progressive respiratory failure due to diffuse inflammatory injury of the alveoli and capillary membrane.

• The lungs fail to oxygenate (not ventilate) → refractory hypoxemia (oxygen won’t rise despite high O₂ delivery).

• Think: Oxygen can’t get in; CO₂ can’t get out.

2. Causes (Common Triggers)

Direct Lung Injury	Indirect/Systemic Injury
Pneumonia	Sepsis (most common cause)
Aspiration	Pancreatitis
Pulmonary contusion	Multiple transfusions
Near-drowning	Shock or trauma

3. Pathophysiology

1. Initial Injury: Damage to alveolar-capillary membrane → inflammatory response.

2. Capillary Permeability ↑: Plasma, proteins, and debris leak into alveoli.

3. Alveolar Collapse: Fluid-filled alveoli = poor gas exchange → ↓ PaO₂.

4. Decreased Compliance: Lungs become stiff and “noncompliant.”

5. Refractory Hypoxemia:

   O₂ cannot diffuse through the fluid-filled alveoli → even 100% FiO₂ doesn’t help.

🧠 Key Concept:

ARDS is an oxygenation failure (not a ventilation failure).

4. Clinical Manifestations

Early Signs	Late Signs
Tachypnea (rapid breathing)	Severe dyspnea, cyanosis
Mild hypoxemia	Use of accessory muscles
Dry cough	Refractory hypoxemia
Restlessness	White-out chest X-ray

5. Diagnostics

ABG Findings:

• ↓ PaO₂ (hypoxemia)

• Respiratory alkalosis (early from tachypnea) → metabolic acidosis (late, from hypoxia/lactate)

PF Ratio (PaO₂/FiO₂):

Severity	PF Ratio
Mild	200–300
Moderate	100–200
Severe	< 100

Normal: > 400

Example:
PaO₂ = 80 on FiO₂ 0.8 → PF = 80/0.8 = 100 → Severe ARDS

Chest X-ray:

• Bilateral infiltrates (“white-out” appearance)

• Looks hazy or opaque = fluid-filled alveoli.

6. Management & Treatment

A. Oxygenation

• Start with high-flow oxygen → usually requires mechanical ventilation.

• PEEP (Positive End-Expiratory Pressure):

  • Keeps alveoli open (“recruits” them).

  • Improves gas exchange.

  • Caution: ↑ PEEP ↓ venous return → may ↓ BP.

B. Ventilator Strategy:

• Low tidal volume (4–6 mL/kg) → prevents further lung injury.

• High PEEP → improves oxygenation.

• Permissive hypercapnia (allowing slightly high CO₂) is acceptable to avoid barotrauma.

C. Positioning:

• Prone positioning (face-down):

  • Improves ventilation-perfusion (V/Q) matching.

  • Decreases pressure from heart/diaphragm on lungs.

  • Usually 16–20 hours/day or longer if tolerated.

  • Protect skin—very high risk of breakdown.

D. Medications & Support:

Goal	Therapy
Sedation & comfort	Propofol, fentanyl, midazolam
Neuromuscular blockade (severe cases)	Nimbex (cisatracurium)
Hemodynamic support	Vasopressors (norepinephrine)
Reduce inflammation	Sometimes corticosteroids
Fluid management	Conservative fluids vs diuretics as tolerated
Prevent clots	Heparin or enoxaparin (DVT prophylaxis)

E. Nutrition:

• Early enteral feeding supports healing and immune function.

7. Nursing Priorities

1. Monitor respiratory status:

   • RR, SpO₂, ABG, work of breathing, lung sounds.

2. Assess hemodynamics:

   • Watch for hypotension (especially with high PEEP).

3. Maintain airway & suction as needed.

4. Optimize positioning:

   • Prone positioning if indicated.

   • Reposition q2h; monitor skin integrity.

5. Cluster care to promote rest.

6. Prevent complications:

   • DVTs, ventilator-associated pneumonia, skin breakdown.

7. Communicate with family:

   • Discuss prognosis, goals of care, and treatment expectations.

8. Prognosis

• Mortality: ~30–50%, higher with sepsis or multi-organ failure.

• Survivors often have prolonged ICU stays and long-term pulmonary weakness.

Quick Summary Table

Category	Key Points
Definition	Oxygenation failure from alveolar injury
Main Cause	Sepsis, pneumonia, aspiration
Key Symptom	Refractory hypoxemia
Diagnostic Test	PF Ratio (< 300 = ARDS)
Chest X-ray	Bilateral infiltrates (white-out)
Main Treatment	Mechanical ventilation with high PEEP
Best Nursing Intervention	Prone positioning + protective lung strategy
Big Risk	Skin breakdown, hypotension from PEEP

1.  On post-MI complications and cardiac tamponade.

• It distills a lecture (Nurse Jenny, Nurse Life Academy) into high-yield, exam-oriented facts.

2. Structure & Key Sections

Question 1: Post-Op CABG Hypotension

• Scenario-based learning: Presents a realistic bedside scenario with BP, heart sounds, JVD, and pulsus paradoxus.

• Diagnosis: Clearly identifies cardiac tamponade as the correct answer.

• Rationale:

  • Lists Beck’s Triad explicitly: hypotension, muffled heart sounds, JVD.

  • Highlights pulsus paradoxus (>10 mmHg drop in systolic BP during inspiration).

  • Notes other supportive signs: tachycardia, low chest tube output, CVP/PAOP equalization.

• Differential diagnoses ruled out:

  • VSR, Dressler Syndrome, Papillary Muscle Rupture, with key distinguishing signs.

  • This section is critical for CCRN-style multiple-choice questions that ask for “most likely cause.”

• Treatment:

  • Post-CABG → OR for drainage

  • Medical → pericardiocentesis

  • Temporizing measures → IV fluids, vasopressors

Question 2: Post-Inferior MI Dyspnea

• Scenario: Inferior MI, acute dyspnea, hypotension, pulmonary congestion.

• Focus: Recognize papillary muscle rupture and cardiogenic shock.

• Key teaching points:

  • Inferior MI → RV involvement → preload-dependent

  • Papillary rupture → acute mitral regurgitation → pulmonary edema + murmur

  • Cardiogenic shock → hypoperfusion, pulmonary congestion, treat with inotropes or mechanical support

3. Study Tips

• Memorization targets: Beck’s Triad, pulsus paradoxus, post-MI complications (VSR, papillary rupture, Dressler’s).

• Inferior MI tips: JVD + clear lungs → fluid responsive; anterior MI → different management.

• Critical interventions: Tamponade → drainage; papillary rupture → emergent surgery.

• Visual cues: EKG leads and murmur locations for rapid recognition.

4. Why This Format Works

• Scenario-based: Mirrors CCRN test style.

• Rationale provided: Explains why the answer is correct and why others are wrong.

• High-yield points bolded: Easy for quick recall.

• Actionable interventions: Lists next steps, not just theory.